MultiCell Technologies, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Dallas, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Multicell Technologies Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Multicell Technologies Inc 52 week high is $0.0005 as of May 11, 2024.
What is the 52-week low for Multicell Technologies Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Multicell Technologies Inc 52 week low is $0.00 as of May 11, 2024.
What is the 50-day moving average of Multicell Technologies Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Multicell Technologies Inc 50-day moving average is $0.00.